---
title: "Pharmaids Pharmaceuticals Ltd (524572) — Share Price, Financials & Analysis"
symbol: "524572"
company: "Pharmaids Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/524572"
isin: "INE117D01018"
nse_symbol: "PHARMAIDSPHARMACEUTICALSLTD"
bse_code: "524572"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 106.1
generated_at: "2026-09-13T19:07:40.310Z"
---

# Pharmaids Pharmaceuticals Ltd (524572)

Canonical page: https://tapetide.com/stocks/524572

## Company

- **NSE Symbol:** PHARMAIDSPHARMACEUTICALSLTD
- **BSE Code:** 524572
- **ISIN:** INE117D01018
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** pharmaids.com

## About

Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services.
It is undergoing a business transition and aims to build a CRDMO platform.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:39.292116Z.

- **Market Cap:** ₹106.1 Cr
- **Classification:** Microcap
- **P/E (reported):** -24.1
- **EPS (TTM):** ₹-1.29
- **EPS (reported):** ₹0
- **Book Value:** ₹13.51
- **Price to Book:** 2.23
- **Dividend Yield:** 0%
- **ROE:** -24.31%
- **ROCE:** -20.25%
- **Debt to Equity:** 0.49
- **Revenue (yearly):** ₹28.2 Cr
- **Net Income:** ₹-11.6 Cr
- **EBITDA:** ₹-13.2 Cr
- **52-Week High:** ₹66
- **52-Week Low:** ₹25.6
- **RSI (14):** 37.62

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Falling
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 17.45 | 9% |
| growth | 64.45 | 9% |
| momentum | 37.93 | 12% |
| ownership | 50 | 24% |
| quality | 44.23 | 22% |
| valuation | 53.97 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Debtor days have improved from 56.1 to 44.9 days.

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding is low: 33.0%
- Company has a low return on equity of -19.4% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 73.13% | 61.77% | — |
| ebitda margin growth | — | -27.33% | -34.66% | — |
| net income growth | 272.73% | -14.07% | -50% | — |
| revenue growth | 15.07% | 43.88% | 20.79% | 47.79% |
| roce | -471.6% | 21.48% | 14.93% | -19.4% |
| roe | -273.15% | -0.94% | -21.88% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0.02 | 5.81 | 4.73 | 5.24 | 4.71 | 4.77 | 6.66 | 8.61 | 5.43 | 7.18 | 4.12 |
| Expenses | 1.02 | 2.45 | 11.39 | 8.14 | 7.65 | 7.6 | 8.67 | 12.03 | 13.93 | 7.94 | 7.52 | 4.87 |
| Operating Profit | -1.02 | -2.43 | -5.58 | -3.41 | -2.41 | -2.89 | -3.9 | -5.37 | -5.32 | -2.51 | -0.34 | -0.75 |
| OPM % | — | -12150 | -96.04 | -72.09 | -45.99 | -61.36 | -81.76 | -80.63 | -61.79 | -46.22 | -4.74 | -18.2 |
| Other Income | -0.26 | 0.76 | 0.12 | -0.07 | 0.08 | 0 | 0.13 | 0.04 | 3.03 | -0.32 | 0.01 | 4.25 |
| Interest | 0 | 0.02 | 0.77 | 0.26 | 0.33 | 0.48 | 1.01 | 1.2 | 0.93 | 0.72 | 0.65 | 0.6 |
| Depreciation | 0.01 | 0.04 | 0.63 | 0.57 | 0.61 | 0.64 | 0.62 | 0.61 | 0.47 | 0.48 | 0.48 | 0.49 |
| Profit before tax | -1.29 | -1.73 | -6.86 | -4.31 | -3.27 | -4.01 | -5.4 | -7.14 | -3.69 | -4.03 | -1.46 | 2.41 |
| Tax % | -60.47 | -33.53 | -7.73 | -27.38 | -30.58 | -24.94 | -11.11 | -26.05 | -30.62 | -34.24 | -25.34 | 22.41 |
| Net Profit | -0.5 | -1.15 | -6.33 | -3.12 | -2.27 | -3.01 | -4.8 | -5.27 | -2.57 | -2.65 | -1.09 | 1.88 |
| EPS in Rs | -0.23 | -0.54 | -1.57 | -0.76 | -0.55 | -0.55 | -1.12 | -1.39 | -0.71 | -0.7 | -0.51 | 0.63 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.94 | 0 | 15.11 | 19.45 | 27.88 | 25.34 |
| Expenses | 3.81 | 9.89 | 27.46 | 32.2 | 41.39 | 34.26 |
| Operating Profit | 0.13 | -9.89 | -12.35 | -12.75 | -13.51 | -8.92 |
| OPM % | 3.3 | — | -81.73 | -65.55 | -48.46 | -35.2 |
| Other Income | 0.02 | 0 | 0.03 | 0.01 | 2.75 | 6.97 |
| Interest | 0 | 0 | 1.58 | 2.1 | 3.52 | 2.9 |
| Depreciation | 0.01 | 0.02 | 1.72 | 2.44 | 2.03 | 1.92 |
| Profit before tax | 0.14 | -9.91 | -15.62 | -17.28 | -16.31 | -6.77 |
| Tax % | 0 | -23.71 | -24.2 | -21.88 | -29 | — |
| Net Profit | 0.15 | -7.56 | -11.85 | -13.51 | -11.57 | -4.43 |
| EPS in Rs | 0.15 | -3.52 | -2.26 | -3.06 | -3.32 | -1.29 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 10.27 | 21.44 | 35.27 | 35.27 | 35.27 |
| Reserves | -1.6 | 1.02 | 36.78 | 24.05 | 12.39 |
| Borrowings | 0 | 0 | 8.53 | 38.98 | 23.39 |
| Other Liabilities | 2.44 | 2.13 | 10.75 | 21.54 | 16.21 |
| Total Liabilities | 11.11 | 24.59 | 91.33 | 119.84 | 87.26 |
| Fixed Assets | 0.03 | 0.11 | 63.42 | 76.61 | 53.94 |
| CWIP | 0.45 | 2 | 7 | 4.53 | 6.1 |
| Investments | 0 | 3.31 | 0 | 0 | 0 |
| Other Assets | 10.63 | 19.17 | 20.91 | 38.7 | 27.22 |
| Total Assets | 11.11 | 24.59 | 91.33 | 119.84 | 87.26 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.26 | -4.02 | -10.62 | -15.11 | -4.06 |
| Cash from Investing Activity | 0.47 | -4.94 | -74.99 | -12.22 | 23.34 |
| Cash from Financing Activity | 0 | 21.31 | 77.66 | 23.36 | -19.97 |
| Net Cash Flow | 0.21 | 12.35 | -7.95 | -3.98 | -0.69 |
| Free Cash Flow | -0.26 | -5.69 | -33.33 | -27.37 | 11.05 |
| CFO/OP | -200 | 41 | 86 | 118 | 30 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 124.14 | — | 64.74 | 58.74 | 44.9 |
| Inventory Days | 90.99 | 0 | 111.61 | 346.51 | 8.73 |
| Days Payable | 236.18 | — | 159.18 | 464.29 | 59.17 |
| Cash Conversion Cycle | -21.05 | — | 17.17 | -59.04 | -5.54 |
| Working Capital Days | -17.6 | — | -68.6 | -160.26 | -172.16 |
| ROCE % | — | -63.67 | -25.99 | -17.43 | -18.48 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 9.7% | 9.25% | 5.64% | 5.56% | 5.19% | 5.22% | 5.22% | 5.14% | 32.99% | 32.99% | 32.99% | 32.99% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 81.93% | 60.78% | 41.06% | 41.14% | 41.03% | 36.42% | 36.59% | 36.35% | 47.02% | 47.24% | 47.44% | 47.59% |
| Others | 8.37% | 29.96% | 53.3% | 53.29% | 53.78% | 58.37% | 58.2% | 58.51% | 19.99% | 19.77% | 19.57% | 19.42% |
| No. of Shareholders | 7393 | 7281 | 7554 | 7594 | 8050 | 8349 | 8220 | 8026 | 8027 | 8288 | 8406 | 8632 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 30.94 | Sell |
| EMA (10) | 30.79 | Sell |
| SMA (20) | 31.54 | Sell |
| EMA (20) | 31.36 | Sell |
| SMA (50) | 32.29 | Sell |
| EMA (50) | 31.92 | Sell |
| SMA (100) | 31.48 | Sell |
| EMA (100) | 32.83 | Sell |
| SMA (200) | 35.94 | Sell |
| EMA (200) | 37.27 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.12 | Neutral |
| MACD (12,26,9) | -0.64 | Sell |
| Stochastic (14,3,3) | 19.23 | Buy |
| ADX (14) | 10.77 | Neutral |
| Williams %R (14) | -81.88 | Buy |
| ATR (14) | 2.49 | High Volatility |
| ROC (12) | -3.41 | Sell |
| Stoch RSI (14) | 16.47 | Buy |
| UO (7,14,28) | 33.05 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 May - FY26 Annual Secretarial Compliance Report filed; no non-compliances or regulatory actions observed. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 8 May - FY26 Annual Secretarial Compliance Report filed; no non-compliances or regulatory actions observed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8e4381e6-3f42-4796-8358-b3e76daa3a25.pdf) |
| 7 Apr - Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6df711a7-2615-4841-a052-51ff8541d73d.pdf) |
| 4m - Diamond Power Infrastructure Limited has informed regarding the Investor Presentation | [Announcement under Regulation 30 (LODR)-Investor Presentation 4m - Diamond Power Infrastructure Limited has informed regarding the Investor Presentation](https://www.bseindia.com/xml-data/corpfiling/AttachLive/718fc110-1e48-4ef3-9544-798193eac9e3.pdf) |
| 2d - Q3 FY26 revenue ₹47,408L, PAT ₹4,972L (+692% YoY); 9M PAT ₹9,755L. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 2d - Q3 FY26 revenue ₹47,408L, PAT ₹4,972L (+692% YoY); 9M PAT ₹9,755L.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0e680b97-3ff0-4558-a687-80e48dd9b9fa.pdf) |
| 27 Mar - Adita Bio Sys sold Siri Labvivo Diet Pvt Ltd to Mr. Shivakumar B G on Mar 27, 2026 for Rs.3,00,000. | [Intimation Under Regulation 30 Of SEBI LODR 27 Mar - Adita Bio Sys sold Siri Labvivo Diet Pvt Ltd to Mr. Shivakumar B G on Mar 27, 2026 for Rs.3,00,000.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d388af81-6ced-420b-a903-bf66ac156978.pdf) |
| 27 Feb - Diamond Power Infrastructure Limited has informed regarding the newspaper publication of special window-Re-lodgement for transfer and dematerialisation of physical securities | [Announcement under Regulation 30 (LODR)-Newspaper Publication 27 Feb - Diamond Power Infrastructure Limited has informed regarding the newspaper publication of special window-Re-lodgement for transfer and dematerialisation of physical securities](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bf813d61-49fa-4b1d-aae3-b3282afb68d0.pdf) |
| 26 Feb - LOI from KPI Green Energy for supply of power cables worth Rs.93.08 crore; execution by June 30, 2026. | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 26 Feb - LOI from KPI Green Energy for supply of power cables worth Rs.93.08 crore; execution by June 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/89582b52-8bfb-433e-8152-ce2e35a83640.pdf) |
| 25 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for year ended Mar 31, 2026. | [Closure of Trading Window 25 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for year ended Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fdc010bf-68a0-4e5c-91b4-e8112631777e.pdf) |
| 24 Feb - 24.02.2026: Adita Bio Sys (material subsidiary) received A2LA accreditation for ISO/IEC17025 and FDA GLP 21 CFR Part 58 testing. | [Intimation Of Receipt Of Accreditation By The American Association For Laboratory Accreditation (A2LA) For Testing Of Medical Devices In Biological Field. 24 Feb - 24.02.2026: Adita Bio Sys (material subsidiary) received A2LA accreditation for ISO/IEC17025 and FDA GLP 21 CFR Part 58 testing.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86c93c7f-70d6-4bcd-8e2e-275aef5ed27e.pdf) |
| 24 Apr - Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 24 Apr - Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4d544c00-2797-4713-808b-971d21bd2b14.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a827b66-93eb-4609-885c-886aad00ede7.pdf) |
| 2026-08-18 | [Notice Of 37Th Annual General Meeting And Annual Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03402968-35d4-4b8b-91b7-f25dacbc8747.pdf) |
| 2026-08-18 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76da073-50c6-4670-b223-55eb1e072998.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c429b36-827e-457f-bebd-4e9948eded97.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Board Meeting Outcome For August 12 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=363ffcf0-c95e-408a-bfb8-c5664590bc5f.pdf) |
| 2026-08-06 | [Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fd357e4-0976-42fc-8fe0-6eaeaf9d2707.pdf) |
| 2026-07-07 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fada5142-04b3-407c-886f-ab47b25292ed.pdf) |
| 2026-06-30 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5eabb7b-d0f1-4fe4-aea7-ba54cb30ece7.pdf) |
| 2026-06-26 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93ba9a8d-bbc2-4cbb-ab78-b12da4a64bd6.pdf) |
| 2026-06-25 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61767283-0994-4236-bd4a-baace790a9d4.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Submission Of Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a98c7437-4713-4079-862e-705ae1958400.pdf) |
| 2026-05-29 | [Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=801cfc6b-6f91-4a80-b735-5a040043d2de.pdf) |
| 2026-02-12 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55bcbeef-5d20-4ebc-b14b-1f8443e75ab0.pdf) |
| 2025-11-11 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa631372-cdd2-4a67-95d7-82bc127c1075.pdf) |
| 2025-08-07 | [Unaudited Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91dccc16-9657-476a-ad13-b791382f2df6.pdf) |
| 2025-05-23 | [Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=605991b9-8f74-4c28-a759-1ab057281fd9.pdf) |
| 2025-02-12 | [Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76f7773f-b11f-4b08-ab19-c5242d7b1e5f.pdf) |
| 2024-11-13 | [Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0993d1cf-1961-466f-9b38-0d93da25c804.pdf) |
| 2024-08-13 | [Results - Financial Results For The Quarter And Three Months Ended 30Th June 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c8c380d-7b02-49b1-afe3-9ab72c417293.pdf) |
| 2024-08-13 | [Results - Financial Results For The Quarter And Three Months Ended 30Th June 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f29f7ca3-9df6-4459-9878-cb77de27feac.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2cfdd875-a7f0-42f8-805b-9fb633329d43.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cee814ce-6dbc-45ae-9975-c622fa6ab9af.pdf) |
| Aug 2015 | [Concall - Aug 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CE35E1C5_E647_47E8_8A62_48EFECA684D9_152526.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1940_DIAPOWER_2012_2013_27092013123324.zip) |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_DIAPOWER_2011_2012_18092012123306.zip) |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_DIAPOWER_2010_2011_09092011022828.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b20c0ca9-ca2a-45cd-a62f-775fba79062f.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09ce10dd-5e9c-4bad-9969-83ac7bde041b.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/16ca69dd-265e-4773-b944-0073d4ad9bbf.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c625898d-ba13-48b2-b16c-3f7a30ce520e.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f20aeef-bc24-4ee3-973d-02c30e428500.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ed722df-c62a-4ec6-9848-81beebc6e0ea.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/349c913f-db14-4bc2-9ba4-8afec9fa2089.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:07:40.310Z.